🇺🇸 FDA
Patent

US 9540415

Inhibitors of the farnesoid X receptor and uses in medicine

granted A61PA61P1/16A61P3/04

Quick answer

US patent 9540415 (Inhibitors of the farnesoid X receptor and uses in medicine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/16, A61P3/04, A61P3/06, A61P3/10